4.8 Article

Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study

期刊

GUT
卷 68, 期 11, 页码 1971-1978

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2019-318593

关键词

-

资金

  1. Johns Hopkins Fisher Center Discovery Program
  2. Kimmel Institute for Cancer Immunotherapy

向作者/读者索取更多资源

Background Microbiome dysbiosis predisposes to colorectal cancer (CRC), but a population-based study of oral antibiotic exposure and risk patterns is lacking. Objective To assess the association between oral antibiotic use and CRC risk. Design A matched case-control study (incident CRC cases and up to five matched controls) was performed using the Clinical Practice Research Datalink from 1989 to 2012. Results 28 980 CRC cases and 137077 controls were identified. Oral antibiotic use was associated with CRC risk, but effects differed by anatomical location. Antibiotic use increased the risk of colon cancer in a dose-dependent fashion (p(trend) < 0.001). The risk was observed after minimal use, and was greatest in the proximal colon and with antibiotics with anti-anaerobic activity. In contrast, an inverse association was detected between antibiotic use and rectal cancers (p(trend)=0.003), particularly with length of antibiotic exposure >60 days (adjusted OR (aOR), 0.85, 95%CI 0.79 to 0.93) as compared with no antibiotic exposure. Penicillins, particularly ampicillin/amoxicillin increased the risk of colon cancer (aOR=1.09 (1.05 to 1.13)), whereas tetracyclines reduced the risk of rectal cancer (aOR=0.90 (0.84 to 0.97)). Significant interactions were detected between antibiotic use and tumour location (colon vs rectum, p(interaction)<0.001; proximal colon versus distal colon, p(interaction)=0.019). The antibiotic-cancer association was found for antibiotic exposure occurring >10 years before diagnosis (aOR=1.17 (1.06 to 1.31)). Conclusion Oral antibiotic use is associated with an increased risk of colon cancer but a reduced risk of rectal cancer. This effect heterogeneity may suggest differences in gut microbiota and carcinogenesis mechanisms along the lower intestinal tract.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Ophthalmology

Predictive Analytics for Glaucoma Using Data From the All of Us Research Program

Sally L. Baxter, Bharanidharan Radha Saseendrakumar, Paulina Paul, Jihoon Kim, Luca Bonomi, TSUNG-TING KUO, Roxana Loperena, Francis Ratsimbazafy, Eric Boerwinkle, Mine Cicek, Cheryl R. Clark, Elizabeth Cohn, Kelly Gebo, Kelsey Mayo, Stephen Mockrin, Sheri D. Schully, Andrea Ramirez, Lucila Ohno-Machado

Summary: This study aimed to validate a model predicting the need for surgery among individuals with glaucoma using All of Us (AoU) data, and found that models trained with AoU data achieved superior performance compared to single-center data. AoU, as a new data source, shows promising potential for ophthalmic research.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Immunology

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

Keri N. Althoff, David J. Schlueter, Hoda Anton-Culver, James Cherry, Joshua C. Denny, Isaac Thomsen, Elizabeth W. Karlson, Fiona P. Havers, Mine S. Cicek, Stephen N. Thibodeau, Ligia A. Pinto, Douglas Lowy, Bradley A. Malin, Lucila Ohno-Machado, Carolyn Williams, David Goldstein, Aymone Kouame, Andrea Ramirez, Adrienne Roman, Norman E. Sharpless, Kelly A. Gebo, Sheri D. Schully

Summary: The study reveals that detectable SARS-CoV-2 immunoglobulin G was found in seven individuals before the first confirmed cases in five US states, indicating that the virus was circulating weeks before recognized cases.

CLINICAL INFECTIOUS DISEASES (2022)

Editorial Material Oncology

Antibiotic Use Impacts Colorectal Cancer: A Double-Edged Sword by Tumor Location?

Jiajia Zhang, Cynthia L. Sears

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Bacterial Genotoxin Accelerates Transient Infection-Driven Murine Colon Tumorigenesis

Yue Liu, Kai Fu, Eric M. Wier, Yifan Lei, Andrea Hodgson, Dongqing Xu, Xue Xia, Dandan Zheng, Hua Ding, Cynthia L. Sears, Jian Yang, Fengyi Wan

Summary: This study identified a novel genotoxin called UshA in attaching/effacing pathogens, which triggers DNA damage and initiates tumorigenic transformation during bacterial infections. Furthermore, it was found that UshA plays a critical role in accelerating colon tumorigenesis in mice. These findings highlight the importance of UshA in the development of colon cancer caused by bacterial infections.

CANCER DISCOVERY (2022)

Article Immunology

Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic

Walid G. El-Nahal, Nicola M. Shen, Jeanne C. Keruly, Joyce L. Jones, Anthony T. Fojo, Bryan Lau, Yukari C. Manabe, Richard D. Moore, Kelly A. Gebo, Catherine R. Lesko, Geetanjali Chander

Summary: Telemedicine became the primary mode of delivering care for people with HIV during the COVID-19 pandemic. The study found that visit completion improved during the pandemic compared to the prepandemic period, especially for certain groups. However, most telemedicine visits were conducted via telephone.
Article Immunology

The shifting age distribution of people with HIV using antiretroviral therapy in the United States

Keri N. Althoff, Cameron N. Stewart, Elizabeth Humes, Jinbing Zhang, Lucas Gerace, Cynthia M. Boyd, Cherise Wong, Amy C. Justice, Kelly A. Gebo, Jennifer E. Thorne, Anna A. Rubtsova, Michael A. Horberg, Michael J. Silverberg, Sean X. Leng, Peter F. Rebeiro, Richard D. Moore, Kate Buchacz, Parastu Kasaie

Summary: This study used an agent-based simulation model to project the future age distribution of people with HIV using antiretroviral therapy (ART) in the United States. The findings suggest a substantial increase in the number of ART-users over time, but also highlight the importance of achieving the ending the HIV epidemic (EHE) goals to reduce HIV diagnoses and address the evolving needs of an aging population with HIV.
Article Public, Environmental & Occupational Health

Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States

Parastu Kasaie, Cameron Stewart, Elizabeth Humes, Lucas Gerace, Jinbing Zhang, Michael J. Silverberg, Michael A. Horberg, Peter F. Rebeiro, Emily P. Hyle, Viviane D. Lima, Cherise Wong, M. John Gill, Kelly Gebo, Richard Moore, Mari M. Kitahata, Keri N. Althoff

Summary: In the 'Treat-All' era, the age distribution of men who have sex with men (MSM) receiving HIV care in the US is predicted to decrease overall, but with significant racial/ethnic disparities, as the proportion of older White MSM on ART is projected to increase rapidly.

ANNALS OF EPIDEMIOLOGY (2022)

Article Immunology

Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America

Kathleen A. McGinnis, Amy C. Justice, Richard D. Moore, Michael J. Silverberg, Keri N. Althoff, Maile Karris, Viviane D. Lima, Heidi M. Crane, Michael A. Horberg, Marina B. Klein, Stephen J. Gange, Kelly A. Gebo, Angel Mayor, Janet P. Tate

Summary: The updated VACS Index 2.0 can reliably estimate all-cause mortality probability among persons with HIV in North America. This study found that predicted mortality rates largely overlapped with observed mortality rates among diverse HIV cohorts, indicating good calibration of the index.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD

Yuhang Qian, Richard D. Moore, Sally B. Coburn, Thibaut Davy-Mendez, Kathleen M. Akgun, Kathleen A. McGinnis, Michael J. Silverberg, Jonathan A. Colasanti, Edward R. Cachay, Michael A. Horberg, Charles S. Rabkin, Jeffrey M. Jacobson, M. John Gill, Angel M. Mayor, Gregory D. Kirk, Kelly A. Gebo, Ank E. Nijhawan, Keri N. Althoff

Summary: This study assessed the predictive ability of the VACS Index 2.0 for hospitalization risk in people with HIV. The results showed that the time-updated VACS Index had the strongest association with hospitalization and best fit to the data.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2022)

Article Public, Environmental & Occupational Health

Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design

Jim Young, Vincent Lo Re, H. Nina Kim, Timothy R. Sterling, Keri N. Althoff, Kelly A. Gebo, M. John Gill, Michael A. Horberg, Angel M. Mayor, Richard D. Moore, Michael J. Silverberg, Marina B. Klein

Summary: Despite the lower risk of ESLD with contemporary antiretrovirals compared to hepatitis coinfection, atazanavir and darunavir still exhibit toxicity signals. Hierarchical Bayesian modeling can be utilized to detect toxicity signals in cohort event monitoring data, even in the presence of complex treatments and few events.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Article Medicine, Research & Experimental

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

Han-Sol Park, Janna R. Shapiro, Ioannis Sitaras, Bezawit A. Woldemeskel, Caroline C. Garliss, Amanda Dziedzic, Jaiprasath Sachithanandham, Anne E. Jedlicka, Christopher A. Caputo, Kimberly E. Rousseau, Manjusha Thakar, San Suwanmanee, Pricila Hauk, Lateef Aliyu, Natalia Majewska, Sushmita Koley, Bela Patel, Patrick Broderick, Giselle Mosnaim, Sonya L. Heath, Emily S. Spivak, Aarthi Shenoy, Evan M. Bloch, Thomas J. Gniadek, Shmuel Shoham, Arturo Casadevall, Daniel Hanley, Andrea L. Cox, Oliver Laeyendecker, Michael J. Betenbaugh, Steven M. Cramer, Heba H. Mostafa, Andrew Pekosz, Joel N. Blankson, Sabra L. Klein, Aaron A. R. Tobian, David Sullivan, Kelly A. Gebo

Summary: Benchmarks for protective immunity from infection or severe disease after SARS-CoV-2 vaccination are still being defined. In this study, the researchers compared different immune responses and viral variants in different groups, including vaccinated individuals and symptomatic patients. The findings showed that neutralizing antibody levels declined over time and were lower against the Alpha variant. Partially and fully vaccinated patients had lower neutralizing antibody levels against the parent virus compared to healthy controls. The study also found that neutralization activity against the Alpha variant was lower in the partially and fully vaccinated infected patients. Parent virus neutralization was identified as a predictive factor for breakthrough infections with the Alpha variant.

JCI INSIGHT (2022)

Article Immunology

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

Sara E. Schad, Andrew Chow, Levi Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia, Justina X. Caushi, Nicole Malandro, Roberta Zappasodi, Mathieu Gigoux, Daniel Hirschhorn, Sadna Budhu, Masataka Amisaki, Monica Arniella, David Redmond, Jamie Chaft, Patrick M. Forde, Justin F. Gainor, Matthew D. Hellmann, Vinod Balachandran, Sohrab Shah, Kellie N. Smith, Drew Pardoll, Olivier Elemento, Jedd D. Wolchok, Taha Merghoub

Summary: This study investigates the characteristics of DP T cells in murine and human tumors, revealing their origin from SP T cells and acquisition of opposite cell type's phenotype and function following TCR stimulation. These findings are significant for understanding tumor immune response and T cell differentiation.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Oncology

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer

Samuel Rosner, Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis Taube, Valsamo Anagnostou, Kellie N. Smith, Joanne Riemer, Peter B. Illei, Stephen R. Broderick, David R. Jones, Suzanne L. Topalian, Drew M. Pardoll, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde

Summary: We present the 5-year clinical outcomes of neoadjuvant nivolumab in resectable non-small cell lung cancer, showing favorable recurrence-free survival (60%) and overall survival (80%) rates. Major pathological responses and tumor PD-L1 positivity are associated with improved recurrence-free survival. This study provides the longest follow-up data for neoadjuvant anti-PD-1 therapy in any cancer type.

CLINICAL CANCER RESEARCH (2023)

Review Microbiology

The microbial landscape of colorectal cancer

Maxwell T. White, Cynthia L. Sears

Summary: This review discusses the significant role of the gut microbiota in the development of colorectal cancer (CRC) and the mechanisms by which specific microorganisms and complex microbial communities contribute to CRC pathogenesis. Despite advancements in understanding the microbiota-CRC relationship, there are substantial gaps in current research that need to be addressed.

NATURE REVIEWS MICROBIOLOGY (2023)

Review Oncology

Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation

Jessica Queen, Fyza Shaikh, Cynthia L. Sears

Summary: Sears and colleagues present the latest advances in understanding the relationship between the microbiome and cancer, and discuss potential applications of this knowledge in cancer therapy. The interactions between the microbiota and cancer, as well as the underlying mechanisms, are an exciting and rapidly evolving field in cancer biology and therapeutics. The authors highlight the role of specific bacteria or their communities in carcinogenesis, and emphasize the bidirectional interplay between the microbiota and host gene or epigenome signaling. They also discuss the potential therapeutic manipulation of the microbiota in cancer patients.

NATURE CANCER (2023)

暂无数据